Edition:
United States

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

11.68USD
16 Feb 2018
Change (% chg)

$-0.50 (-4.11%)
Prev Close
$12.18
Open
$12.05
Day's High
$12.35
Day's Low
$11.58
Volume
7,604
Avg. Vol
14,562
52-wk High
$16.59
52-wk Low
$8.80

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-18 5 3.75 8.76 2.10 1.00
Quarter Ending Jul-18 5 5.09 14.30 2.10 1.00
Year Ending Jan-18 6 35.46 42.24 31.60 8.97
Year Ending Jan-19 7 18.38 43.30 8.40 9.08
Earnings (per share)
Quarter Ending Apr-18 2 -0.60 -0.51 -0.68 --
Quarter Ending Jul-18 2 -0.55 -0.42 -0.68 --
Year Ending Jan-18 1 -0.41 -0.41 -0.41 -1.11
Year Ending Jan-19 2 -1.53 -1.49 -1.58 -0.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) -- 140.57 8.57
Price to Book (MRQ) -- 18.76 5.14
Price to Tangible Book (MRQ) -- 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions -- 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) -- 6.17 3.38
LT Debt to Equity (MRQ) -- 16.64 11.85
Total Debt to Equity (MRQ) -- 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -- -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -- -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -- -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,305,201 819,569,446
Net Income/Employee (TTM) -- -626,600 95,804,981
Receivable Turnover (TTM) -- 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) -- 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -- -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -- -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91

Performance for Summit Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.50%
# of Holders: 23
Total Shares Held: 4,025,982
3 Mo. Net Change: -37,315
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 5
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.